Clinical trial · Observational
Outcome Measures in Infant/Early Childhood Lung Disease w/ Chest CT Scanning & Lung Function Testing
Differentiating Outcome Measures in Infant and Early Childhood Lung Disease Utilizing Controlled Ventilation Infant/Young Child Chest CT Scanning and Lung Function Testing
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To implement a new method of performing chest CT imaging in young children at Packard Children's Hospital entitled controlled ventilation infant/young child chest CT scanning. This technique will be used to evaluate early lung disease comparing quantitative chest CT air trapping and airway measurements with lung function measurements in infants, toddlers, and young children with chronic lung disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CT scan Radiation | Procedure | — | UNRESOLVED |
| Intubation with a cuffed ET Tube | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Quantitative CT air trapping & airway measurements
- timeFrame
- 6 mo
Secondary outcomes (4)
- measure
- Functional residual capacity (FRC) & Lung Clearance Index (LCI).
- timeFrame
- 6 mo
- measure
- Differences between Quantitative CT air trapping & airway measurements & multibreath washout (MBW) FRC and LCI.
- timeFrame
- 6 mo
- measure
- Correlation between LCI and quantitative air trapping
- timeFrame
- 6 mo
- measure
- Correlation between bronchial wall thickness measurements/bronchiectasis measurements and LCI/FRC
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Months
- Maximum age
- 5 Years
Show eligibility criteria text
Inclusion Criteria:1) Infants and young children (age \<= 3 months to \< 5 years) and either 2) or 3) below. 2\) Respiratory condition (e.g. cystic fibrosis (CF), primary ciliary dyskinesia, bronchopulmonary dysplasia, asthma, or other pulmonary condition) and under the care of a pediatric pulmonologist at LPCH. 3\) Oncology condition (e.g. young children with or without cancer, who are being screened for lung metastasis) and are being followed by pediatric oncologists at LPCH. 4\) For minors, informed consent by parent or legal guardian. 5\) Ability to comply with study visit procedures as judged by the investigator. Exclusion Criteria:1) Acute wheezing and/or respiratory distress at Study visit. 2\) Acute intercurrent respiratory infection, defined as an increase in cough, wheezing, or respiratory rate with onset in 1 week preceding Study visit. 3\) Oxygen saturation \< 90% on room air at study visit. 4\) Any medical condition that in the opinion of the investigator precludes subject participation.
References
Publications (0)
Data not yet available